Giving
clot-busting drugs through the arteries rather than the veins may improve the
chances of a good outcome in stroke patients who receive prompt treatment, according
to a study reported in the January issue of Neurosurgery. Ohio
State University researcher Eric Bourekas and his colleagues analyzed the results
of treating strokes through the arteries in 36 patients treated within three hours
after the first symptoms. Providing
clot-busting drugs through the arteries improved flow in the blocked blood vessel
in 75 percent of patients. In 39 percent, flow was restored completely. These
rates were nearly twice as high as past studies had reported that involved patients
receiving such drugs through the standard intravenous route. One
to three months after such treatment, 50 percent of the patients treated through
the arteries had little or no disability resulting from their stroke, compared
to a 39 percent rate for patients in a landmark National Institute of Neurological
Disorders and Stroke (NINDS) study of early intravenous clot-busting therapy. The
risk of bleeding problems was 11 percent for patients treated through the arteries
or slightly higher than in the NINDS study. The risk of death in patients receiving
intra-arterial therapy was 22 percent, similar to that with intravenous therapy. The
researchers said their findings suggest that providing clot-busting drugs through
the arteries improves the chances of disability-free outcomes in patients with
stroke. This
probably reflects the higher success rate in reopening the blocked artery, achieved
by delivering a higher concentration of the clot-dissolving drug directly to the
area of blockage, according to the researchers. Dr.
Bourekas and colleagues called for more research to compare the results of intravenous
versus intra-arterial clot-busting therapy. However, because the latter is more
invasive, they emphasize that it should only be performed at hospitals with specialized
stroke teams available around the clock. Other
sources: Neurosurgery 54: 3, 2004
|